BMO | Erosion | Sclerosis | Fat metaplasia | ||||||
B | P value | B | P value | B | P value | B | P value | ||
Female | HLA-B27 | 0.240 | 0.130 | 0.079 | 0.676 | 0.012 | 0.942 | −0.056 | 0.751 |
BMI | 0.456 | 0.006 | 0.073 | 0.700 | 0.515 | 0.003 | −0.089 | 0.616 | |
Age | 0.062 | 0.682 | 0.079 | 0.664 | −0.075 | 0.635 | −0.175 | 0.310 | |
CRP | 0.335 | 0.031 | 0.241 | 0.191 | −0.141 | 0.374 | 0.338 | 0.055 | |
Male | HLA-B27 | −0.643 | 0.007 | 0.242 | 0.158 | 0.472 | 0.064 | 0.066 | 0.587 |
BMI | −0.439 | 0.055 | 0.168 | 0.331 | 0.300 | 0.237 | 0.051 | 0.685 | |
Age | 0.269 | 0.205 | −0.136 | 0.410 | −0.233 | 0.336 | −0.223 | 0.077 | |
CRP | −0.135 | 0.520 | 0.785 | <0.001 | -0.075 | 0.757 | 0.895 | <0.001 |
B=standardised coefficient beta. p=significance level. Statistically significant results (p < 0.05) are marked in bold.
BMI, body mass index; BMO, bone marrow oedema; CRP, C reactive protein.